Results 211 to 220 of about 738,105 (258)

Gut-liver axis dysregulation and restoration in decompensated hepatitis B cirrhosis: rationale and research progress of fecal microbiota transplantation. [PDF]

Front Microbiol
Gao S, Zhuang J, Cheng H, Hu K, Zhuang L, Pan Y.   +5 more
europepmc   +1 more source

Protocol for the Therapy Personalisation Using Multiomic Analyses in Inflammatory Bowel Disease (THAMES‐IBD) Study

JCC Plus, Volume 1, Issue 6, November 2026.
ABSTRACT Background Despite an expanding repertoire of advanced therapies for inflammatory bowel disease (IBD), treatment outcomes remain suboptimal, with only 30%–40% of patients achieving sustained remission. Emerging evidence indicates that therapeutic outcomes are shaped by complex interactions between host immune pathways, the gut microbiome and ...
John P. Thomas, Aamir Saifuddin, Sadek Malas, Meztli Matadamas Guzman, Cristina Di Poto, Dimple Dixit, Isabel Laszczak, H. Sophia Chung, Erik L. Allman, Yang Song, James L. Alexander, Bat‐Erdene Jugder, Ailsa Hart, Kyle Bednar, Nick Powell   +14 more
wiley   +1 more source

Fecal microbiota transplantation for chronic constipation following bowel surgery in an elderly patient: A case report. [PDF]

Medicine (Baltimore)
Liao DX, Zhang S, Cao D, Cai X, Sun HL, Jin WD, Fu T.   +6 more
europepmc   +1 more source

Sepsis: Epidemiology, Pathophysiology, and Management

MedComm, Volume 7, Issue 11, November 2026.
Sepsis remains a major global health burden characterized by substantial geographical heterogeneity and a considerable disease burden in China. Its pathophysiology reflects an interconnected network involving excessive inflammation, oxidative stress, immune imbalance and immunoparalysis, mitochondrial damage, endothelial injury, gut dysbiosis ...
Guang‐Tao Pan, Yu Deng, Lin‐Rui Ma, Yu‐Tong Li, Yu Qian, Yi‐Hua Ma, Hai‐Wei Rao, Yi‐Zhun Zhu, Pei‐Yu Yan   +8 more
wiley   +1 more source

Microbial engraftment and immune regulation during fecal microbiota transplantation and immune checkpoint inhibitor therapy. [PDF]

Nat Commun
Ninkov M, Maleki Vareki S.
europepmc   +1 more source

Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies

MedComm, Volume 7, Issue 11, November 2026.
Neurodegenerative diseases share convergent risk architectures and pathological mechanisms, yet diverge in selective vulnerability, clinical presentation, and therapeutic responsiveness. This review integrates cross‐disease epidemiology, pathophysiology, diagnosis, and treatment, highlighting the transition from symptomatic care toward biomarker‐guided
Zimeng He, Jingjing Zeng, Guoqing Wang, Yuxin Li, Feng Zhang   +4 more
wiley   +1 more source

Combined fecal microbiota transplantation and adipose-derived stem cells protect the blood-spinal cord barrier after spinal cord injury. [PDF]

Front Immunol
Tang Z, Chen J, Peng D, Mo B, Yao S, Xie H, Jiang D, Zhuo W, Zhang H, Zhou Z.   +9 more
europepmc   +1 more source

Gastric Cancer: Epidemiology, Risk Factors, Pathogenesis, Clinical Features, Diagnosis, and Management

MedComm, Volume 7, Issue 11, November 2026.
This comprehensive review summarizes gastric cancer epidemiology, multifactorial risk factors (like infectious, dietary, genetic), pathogenesis such as precancerous evolution, molecular alterations, and a focus on the bidirectional interactions between gastric cancer cells and macrophages in the tumor microenvironment.
Yixuan Xin, Xingya Wang, Yangtao Wu, Qian Liu, Qian Ren, Hui Wang, Jingbo Zhai   +6 more
wiley   +1 more source

Colonoscopic or Capsule Fecal Microbiota Transplantation for Recurrent <i>Clostridioides difficile</i> Infection: A Prospective Cohort. [PDF]

Gastro Hep Adv
Belhasan D, Kuchma N, Fischer M, Allegretti JR, Kelly CR, Khoruts A, Vaughn BP.   +6 more
europepmc   +1 more source